Cargando…
Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1
OBJECTIVE: Lupus nephritis (LN) affects almost half of all individuals with systemic lupus erythematosus (SLE). Overt LN (OLN) symptoms might vary from asymptomatic microscopic hematuria to renal failure. However, when there are no clinical or laboratory indicators of renal involvement, some people...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482965/ https://www.ncbi.nlm.nih.gov/pubmed/36133925 http://dx.doi.org/10.2147/OARRR.S373589 |
_version_ | 1784791567859449856 |
---|---|
author | Gouda, Wesam Abd elaziz Alsaid, Aldosoky Abbas, Awad Saad Abdel-Aziz, Tarek M Shoaeir, Mohamed Z Abd Elazem, Abd Allah S Sayed, Mohammad Hamdy |
author_facet | Gouda, Wesam Abd elaziz Alsaid, Aldosoky Abbas, Awad Saad Abdel-Aziz, Tarek M Shoaeir, Mohamed Z Abd Elazem, Abd Allah S Sayed, Mohammad Hamdy |
author_sort | Gouda, Wesam |
collection | PubMed |
description | OBJECTIVE: Lupus nephritis (LN) affects almost half of all individuals with systemic lupus erythematosus (SLE). Overt LN (OLN) symptoms might vary from asymptomatic microscopic hematuria to renal failure. However, when there are no clinical or laboratory indicators of renal involvement, some people with silent LN (SLN) may have pathological evidence of renal involvement identified by renal biopsy. Monocyte Chemotactic Protein 1 (MCP-1) is a chemotactic factor that promotes leukocyte migration to the kidney. MCP-1 urine levels (uMCP-1) have been demonstrated to be high in individuals with active LN. The purpose of this study was to discover the occurrence of SLN, as well as the possible variations between overt LN (OLN) and SLN across SLE patients based on the histopathological assessment, as well as the role of uMCP-1 in the early detection of SLN. METHODS: An overall of 144 patients with SLE were included in the current research. Patients were subsequently divided into two groups: individuals who did not have clinical evidence of LN (84 patients) and those with OLN (60 patients). All the patients were subjected to the following investigations: uMCP-1, erythrocyte sedimentation rate (ESR), complement C3 (C3), complement C4 (C4), creatinine, albumin/creatinine ratio (uACR), creatinine clearance, quantitative assessment of proteinuria by 24-hour urine proteinuria (24hr UP) and percutaneous renal biopsy. RESULTS: Sixty patients from group I (71.4%) showed glomerular lesions on renal biopsy (SLN), and class II was the predominant class. uMCP-1 had a sensitivity of 95.2% and a specificity of 98% in the detection of SLN, and uMCP-1 values were markedly higher in patients with OLN in comparison to SLN. CONCLUSION: The actual frequency of SLN may be higher than expected. High levels of uMCP-1 may have warranted the early activity of LN. uMCP-1 can be used as a non-invasive, useful tool for the prediction of LN. |
format | Online Article Text |
id | pubmed-9482965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-94829652022-09-20 Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1 Gouda, Wesam Abd elaziz Alsaid, Aldosoky Abbas, Awad Saad Abdel-Aziz, Tarek M Shoaeir, Mohamed Z Abd Elazem, Abd Allah S Sayed, Mohammad Hamdy Open Access Rheumatol Original Research OBJECTIVE: Lupus nephritis (LN) affects almost half of all individuals with systemic lupus erythematosus (SLE). Overt LN (OLN) symptoms might vary from asymptomatic microscopic hematuria to renal failure. However, when there are no clinical or laboratory indicators of renal involvement, some people with silent LN (SLN) may have pathological evidence of renal involvement identified by renal biopsy. Monocyte Chemotactic Protein 1 (MCP-1) is a chemotactic factor that promotes leukocyte migration to the kidney. MCP-1 urine levels (uMCP-1) have been demonstrated to be high in individuals with active LN. The purpose of this study was to discover the occurrence of SLN, as well as the possible variations between overt LN (OLN) and SLN across SLE patients based on the histopathological assessment, as well as the role of uMCP-1 in the early detection of SLN. METHODS: An overall of 144 patients with SLE were included in the current research. Patients were subsequently divided into two groups: individuals who did not have clinical evidence of LN (84 patients) and those with OLN (60 patients). All the patients were subjected to the following investigations: uMCP-1, erythrocyte sedimentation rate (ESR), complement C3 (C3), complement C4 (C4), creatinine, albumin/creatinine ratio (uACR), creatinine clearance, quantitative assessment of proteinuria by 24-hour urine proteinuria (24hr UP) and percutaneous renal biopsy. RESULTS: Sixty patients from group I (71.4%) showed glomerular lesions on renal biopsy (SLN), and class II was the predominant class. uMCP-1 had a sensitivity of 95.2% and a specificity of 98% in the detection of SLN, and uMCP-1 values were markedly higher in patients with OLN in comparison to SLN. CONCLUSION: The actual frequency of SLN may be higher than expected. High levels of uMCP-1 may have warranted the early activity of LN. uMCP-1 can be used as a non-invasive, useful tool for the prediction of LN. Dove 2022-09-14 /pmc/articles/PMC9482965/ /pubmed/36133925 http://dx.doi.org/10.2147/OARRR.S373589 Text en © 2022 Gouda et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Gouda, Wesam Abd elaziz Alsaid, Aldosoky Abbas, Awad Saad Abdel-Aziz, Tarek M Shoaeir, Mohamed Z Abd Elazem, Abd Allah S Sayed, Mohammad Hamdy Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1 |
title | Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1 |
title_full | Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1 |
title_fullStr | Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1 |
title_full_unstemmed | Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1 |
title_short | Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1 |
title_sort | silent lupus nephritis: renal histopathological profile and early detection with urinary monocyte chemotactic protein 1 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482965/ https://www.ncbi.nlm.nih.gov/pubmed/36133925 http://dx.doi.org/10.2147/OARRR.S373589 |
work_keys_str_mv | AT goudawesam silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1 AT abdelazizalsaidaldosoky silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1 AT abbasawadsaad silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1 AT abdelaziztarekm silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1 AT shoaeirmohamedz silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1 AT abdelazemabdallahs silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1 AT sayedmohammadhamdy silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1 |